INJECTAPLAS LIMITED

Company Registration Number:
04628580 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2025

Period of accounts

Start date: 01 January 2025

End date: 31 December 2025

INJECTAPLAS LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2025

Balance sheet
Notes

INJECTAPLAS LIMITED

Balance sheet

As at 31 December 2025


Notes
2025
2024


£
£
Fixed assets
Tangible assets: 3 79,723 103,612
Total fixed assets: 79,723 103,612
Current assets
Stocks: 100,830 105,960
Debtors:   172,097 170,607
Cash at bank and in hand: 126,404 148,253
Total current assets: 399,331 424,820
Creditors: amounts falling due within one year: 4 (143,357) (198,346)
Net current assets (liabilities): 255,974 226,474
Total assets less current liabilities: 335,697 330,086
Provision for liabilities: (19,931) (25,904)
Total net assets (liabilities): 315,766 304,182
Capital and reserves
Called up share capital: 25,000 25,000
Profit and loss account: 290,766 279,182
Shareholders funds: 315,766 304,182

The notes form part of these financial statements

INJECTAPLAS LIMITED

Balance sheet statements

For the year ending 31 December 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 18 September 2026
and signed on behalf of the board by:

Name: C W D WHELAN
Status: Director

The notes form part of these financial statements

INJECTAPLAS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

INJECTAPLAS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

2. Employees

2025 2024
Average number of employees during the period 3 3

INJECTAPLAS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

3. Tangible Assets

Total
Cost £
At 01 January 2025 128,869
At 31 December 2025 128,869
Depreciation
At 01 January 2025 25,257
Charge for year 23,889
At 31 December 2025 49,146
Net book value
At 31 December 2025 79,723
At 31 December 2024 103,612

INJECTAPLAS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

4. Creditors: amounts falling due within one year note

TRADE CREDITORS £80,959 TAXATION £ 42,375 ACCRUALS £12,106 HIRE PURCHASE £1,933 OTHER CREDITORS £5,984

INJECTAPLAS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

5. Related party transactions

PLASTIC WHEELS LIMITED IS REGARDED BY THE DIRECTORS AS BEING THE COMPANY'S ULTIMATE PARENT COMPANY